Filing Details
- Accession Number:
- 0001765581-22-000047
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-11 17:29:53
- Reporting Period:
- 2022-05-09
- Accepted Time:
- 2022-05-11 17:29:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1784606 | Patricia Carr | 5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2 | Svp, Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2022-05-09 | 1,056 | $148.93 | 7,240 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2022-05-09 | 11 | $150.49 | 7,229 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2022-05-10 | 273 | $144.18 | 6,956 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2022-05-11 | 722 | $147.51 | 6,234 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.92 to $149.91 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.11 to $144.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.51 to $147.65. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Billionaire Hedge Funds
